Beta Bionics (BBNX) TD Cowen 46th Annual Health Care Conference summary

Product differentiation and market positioning

• iLet insulin pump features automation, requiring minimal patient and provider engagement, and adapts to individual needs through a learning algorithm.

• The product reduces setup and management burden for healthcare providers, enabling broader prescription without specialized pump knowledge.

• Business model leverages pharmacy reimbursement, aiming for earlier free cash generation and faster innovation cycles.

• Success is attributed to addressing both tech-savvy early adopters and patients who struggle with other pumps, with 70% of new users coming from injections and high baseline A1c.

• The company aims to integrate with all CGMs and offer both patch and tubed pumps, focusing on pharmacy channel access to maximize market reach.

Competitive landscape and industry trends

• Main competitors win market share through patch pump form factor and exclusive pharmacy reimbursement.

• The industry is shifting toward automated, learning-based algorithms, validating the automation-forward approach.

• Barriers to adoption include entrenched clinical practices and patient preferences for manual control or specific form factors.

• The pay-as-you-go pharmacy model is becoming industry standard, pioneered by the company and now adopted by competitors.

• The market remains under-penetrated, especially in primary care and among Type 2 diabetes patients.

Sales force expansion and commercial strategy

• Currently operates 63 sales territories, planning to add at least 20 more in 2026, with a long-term target of 120–180 territories for full U.S. coverage.

• Sales force size is 25–50% that of competitors, but market share in covered territories exceeds 10%.

• New sales territories typically generate incremental revenue within a quarter of hiring.

• Deliberate, quality-focused hiring strategy prioritizes high-performing salespeople and leverages strong company culture.

• Anticipates significant hiring and expansion around the commercial launch of the Mint patch pump by end of 2027.